Javier Solsona Caravaca

Myocarditis and look-alikes: when the diagnosis matters heart.bmj.com/content/early/…

@AlbertoCereda1 eurointervention.pcronline.com/article/patchi…

9/ 🫀 El calcio coronario gana protagonismo El score de calcio se convierte en una herramienta clave para decidir tratamiento. Escenarios: 🔴 ≥1000 AU ➡️ Reducir LDL ≥50% 🎯 Objetivo: <55 mg/dL 🟠 300–999 AU ➡️ Reducir LDL ≥50% 🎯 Objetivo: <70 mg/dL ⬇️ Intensificación razonable hasta <55 mg/dL 🟡 100–299 AU (o ≥ percentil 75) ➡️ Reducir LDL ≥50% 🎯 Objetivo: <70 mg/dL 🟢 1–99 AU (y < percentil 75) 💊 Estatinas de intensidad moderada 🎯 Objetivo: LDL <100 mg/dL

🫀An Expert Overview of Durability of M-TEER via #JACCIntervention ✅️ M-TEER durability up to 5 y remains understudied. ✅️ M-TEER failure 📈 af 3 y | primary MR > than secondary MR. ✅️ MR recurrence rates are relatively high after redo M-TEER. doi.org/10.1016/j.jcin…

Pearls and pitfalls in the diagnosis and management of mitral annular calcification bit.ly/4avjx60

#EHJIMP 🫀 TR regression after M-TEER 💡 Tricuspid valve annulus perimeter was the strongest predictor of TR regression in this study including 61 patients who underwent pre+post 3D #echofirst. Annulus area and area change also predicted TR⬇️. Read more: doi.org/10.1093/ehjimp…

Rangos de referencia del Strain Longitudinal Global (SLG) por ecocardiografía. 🔗DOI: 10.1016/j.jcmg.2023.08.011

#YesCCT for the “forgotten valve”? In this outcomes study of TR, a higher #YesCCT tricuspid anatomic regurgitant orifice area was assoc w/ worsening right heart remodeling & mortality jacc.org/doi/10.1016/j.… #JACCIMG @sarano_maurice @JoaoLCavalcante @bapat_savrtavr @Miho_Fukui_

Valor pronóstico del índice de acoplamiento auriculo-ventricular izquierdo en la insuficiencia cardíaca 👓 buff.ly/08irxsj ◀️ Si en una CMR de IC con FEVI <50% encontramos una AI muy aumentada para un VI no tan dilatado, el IAAV ayuda a poner número a esa impresión clínica y a considerarlo una bandera roja de riesgo (junto a LGE, función, congestión y comorbilidad), más que un dato aislado de tamaño En "García Fernández te pone al día"

🫀 New in European Heart Journal – Imaging Methods & Practice This article presents a **step-by-step protocol for using transthoracic and transoesophageal echocardiography to guide tricuspid transcatheter edge-to-edge repair (TEER). It offers practical imaging guidance on anatomy, views, and procedural planning—valuable for structural heart teams and echo specialists. 📸 Key imaging takeaways: • Standardised TTE & TEE views for tricuspid valve assessment • Protocol to optimise 3D en face visualisation and leaflet grasping • Tips to reduce procedural uncertainty and improve procedural success • Practical approach rooted in real-world structural interventions 🔗 doi.org/10.1093/ehjimp… #CardioTwitter #EACVI #Echo #TricuspidTEER #StructuralHeart #CardiacImaging

#echofirst Routine Echocardiographic Assessment in LVAD Patients—A Structured Approach to Acquisition and Interpretation mdpi.com/3704962 #mdpijcdd via @JCDD_MDPI

🔴Myocarditis & look-alikes: when the diagnosis matters @Heart_BMJ #Cardiology #CardioEd #Myocarditis

Sex-specific prognostic thresholds of left ventricular hypertrophy in fabry disease In FD patients, sex-specific prognostic thresholds of LVH were identified, with women experiencing cardiovascular events at significantly lower values of LVMWT than men, even after accounting for BSA #Cardiology #MedTwitter #CardioTwitter #HeartHealth #Healthcare @ESC_Journals @JACCJournals @EACVIPresident academic.oup.com/ehjcimaging/ad…

📌The year in cardiovascular medicine 2025: the top 10 papers in valvular heart disease #VHD #EHJ #TopPapers

TTVR + CIED leads: What really happens? Insights from the TRIPLACE Registry in #JACCEP 🎯 Same procedural success ⚠️ Lead failure 5.8% 🫀 More ≥moderate PVL ✅ 30-day mortality not increased Free (50 days): authors.elsevier.com/a/1mUZ6,siTgof… @MontefioreNYC @EinsteinMed @JACCJournals

🚨 Can echocardiography really exclude HFpEF? New data say: not reliably. A large, invasive hemodynamics–validated study tested the updated 2025 ASE diastolic function grading algorithm in patients with confirmed HFpEF — and the results are eye-opening. 👀 🔍 Key finding: Among ambulatory patients with invasively proven HFpEF, ~68% were classified as “normal” or Grade 1 diastolic dysfunction by the new ASE criteria. Yet >60% of these patients already had elevated filling pressures at rest, and many worsened dramatically with exercise. 🏃‍♂️ Stress echo underperformed: In patients labeled Grade 1 (where exercise testing is recommended), the ASE 2025 stress criteria detected HFpEF in only ~10% — a false-negative rate >90%. Even under “best-case” assumptions, sensitivity remained poor. 🏥 Volume status matters: Diastolic grades shifted substantially between decompensated and recompensated states. After diuresis, over 50% of hospitalized HFpEF patients reverted to normal or Grade 1, highlighting how load-dependent and unstable diastolic grading can be. 📉 Diagnostic performance: Overall discrimination for HFpEF vs non-cardiac dyspnea was modest (AUC ~0.61) — inferior to probability-based tools like H₂FPEF, especially when combined with functional testing. ⚠️ Prognostic paradox: Patients with HFpEF labeled “normal” or Grade 1 still had a ~5-fold higher risk of death or HF hospitalization compared with controls. 💡 Bottom line: 🛑 Normal diastolic function ≠ no HFpEF. Echocardiography remains essential — but diastolic grades must be interpreted within pretest probability frameworks, not used in isolation to rule out disease.

A Large Left Ventricular Cystic Thrombus: Unusual Presentation of a Common Entity 🔗 2017 Dec 19;1(6):216-220. DOI: 10.1016/j.case.2017.09.009

#EHJCVI 🧲 Is CMR redefining timing in chronic aortic regurgitation? A meta-analysis (~2,000 pts) shows CMR-derived AR fraction >33% is linked to ~4× higher risk, even in asymptomatic patients. CMR sharpens risk stratification beyond echo 👉 doi.org/10.1093/ehjci/…

Circumflex artery (RCX) seen in #3DTEE running in the left AV groove - potentially at risk of injury (mostly due to traction) in patients undergoing MV surgery @CASivaram1 👌#echofirst

Los 5 trabajos de CRMN del 2025 ,según mis preferencias….muchísimo gadolinio!! 1.Messroghli DR, Moon JC, Ferreira VM, et al. Stress perfusion cardiac magnetic resonance for risk stratification in chronic coronary syndromes. European Heart Journal – Cardiovascular Imaging. 2025;26(7):801–812. 2.Treibel TA, Bandula S, Fontana M, et al. Native T1 mapping and extracellular volume quantification for prediction of outcomes in non-ischemic cardiomyopathy. Journal of the American College of Cardiology. 2025;85(15):1456–1468. 3.Petersen SE, Aung N, Sanghvi MM, et al. Cardiac magnetic resonance–derived phenotypes and outcomes in heart failure with preserved ejection fraction. European Heart Journal. 2025;46(10):901–912. 4.Neilan TG, Coelho-Filho OR, Shah RV, et al. Cardiac magnetic resonance markers of myocardial injury and prognosis after myocarditis. JACC: Cardiovascular Imaging. 2025;18(6):721–732. 5.Kramer CM, Bluemke DA, Hundley WG, et al. Prognostic significance of quantitative late gadolinium enhancement assessed by cardiac magnetic resonance. Circulation. 2025;151(8):612–623.